TRN-157

· Theron Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TRN-157, covering 2014-10-31 to 2017-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics [Phase 2]